Acute AT1 receptor blockade does not improve the depressed baroreflex in rats with chronic renal hypertension

Brazilian Journal of Medical and Biological Research

Volumn 33, Issue 12, 2000, Pages 1491-1496

  Farah, V M A ^a   Moreira, E D ^a   Ushizima, M ^a   Cestari, I A ^a   Irigoyen, M C ^a   Krieger, E M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin II; Baroreflex sensitivity; Losartan; Renal hypertension

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; LOSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; BRADYCARDIA; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PLASMA RENIN ACTIVITY; PRESSORECEPTOR REFLEX; RAT; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; TACHYCARDIA;

ANIMALIA;

EID: 0034513548     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2000001200014     Document Type: Article

References (20)

1. Guo GB & Abboud FM (1984). Impaired central mediation of the arterial baroreflex in chronic renal hypertension. American Journal of Physiology, 246: H720-H727.
2. Irigoyen MC, Moreira RD, Moreira ED & Krieger EM (1991). High-renin renal hypertension depresses the baroreflex control of heart rate and sympathetic activity. In: Kunos G & Ciriello J (Editors), Central Neural Mechanisms of Blood Pressure Regulation. Birkhauser Boston Inc., Boston, MA, 254-264.
3. Moreira ED, de Oliveira M & Krieger EM (1988). Impaired baroreflex control of heart rate in high-renin renal hypertension. Journal of Hypertension, 6: 619-625.
4. Casto R & Phillips MI (1986). Angiotensin II attenuates baroreflex at nucleus tractus solitarius of rats. American Journal of Physiology, 250: R193-R198.
5. Sleight P (1989). The relevance of baroreflex mechanisms to the control of ambulatory and exercise blood pressure in humans. Clinical and Experimental Pharmacology and Physiology, 15 (Suppl): 65-69.
6. Moreira ED, Ida F & Krieger EM (1990) Reversibility of the baroreceptor hyposensitivity during reversal of hypertension. Hypertension, 15: 791-796.
7. Leenen FHH & Myers MG (1984). Pressor mechanisms in renovascular hypertensive rats. In: de Jong W (Editor), Handbook of Hypertension. Vol. 4: Experimental and Genetic Models of Hypertension. Elsevier Science Publishers B.V., Amsterdam, The Netherlands, 24-80.
8. Dzau VJ & Pratt RE (1992). Renin-angiotensin system. In: Fozzard HÁ (Editor), The Heart and Cardiovascular System. Raven Press, New York, 1817-1849.
9. Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL & Timmermans PBMWM (1990). Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent. Journal of Pharmacology and Experimental Therapeutics, 252: 719-725.
10. Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL & Timmermans PBMWM (1990). Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent. Journal of Pharmacology and Experimental Therapeutics, 252: 726-732.
11. Moreira ED, Ida F, Pires MD & Krieger EM (1994). DuP 753 is more effective than captopril on baroreceptor function in high-renin hypertension. Hypertension, 23 (Suppl I): I-64-I-67.
12. Farah VMA, Moreira ED, Pires MD, Irigoyen MCC & Krieger EM (1999). Comparison of three methods for the determination of baroreflex sensitivity in conscious rats. Brazilian Journal of Medical and Biological Research, 32: 361-369.
13. Leite R & Salgado COM (1992). Increased vascular formation of angiotensin II in one-kidney, one-clip hypertension. Hypertension, 19; 575-581.
14. Swales JD (1979). Arterial wall or plasma renin in hypertension. Clinical Science, 56: 293-298.
15. Thurston H, Swales JD, Bing RF, Hurst BC & Marks ES (1979). Vascular renin-like activity and blood pressure maintenance in the rat. Hypertension, 1: 643-649.
16. Unger T, Chung O, Csikos T, Culman J, Gallinat S, Gohlke P, Höhle S, Meffert S, Stoll M, Stroth U & Zhu YZ (1996). Angiotensin receptors. Journal of Hypertension, 14 (Suppl 5): S95-S103.
17. Gigante B, Piras O, De Paolis P, Porcellini A, Natale A & Volpe M (1998). Role of the angiotensin II AT2-subtype receptors in the blood pressure-lowering effect of losartan in salt-restricted rats. Journal of Hypertension, 16: 2039-2043.
18. Siragy HM & Carey RM (1997). The sub-type 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. Journal of Clinical Investigation, 100: 264-269.
19. Santos CM, Pontieri V, Neto ML & Michelini LC (1995) Losartan improves baroreflex control of heart rate of coarcted hypertensive rats. American Journal of Physiology, 269: H812-H818.
20. Santos CM, Moreira ED, Krieger EM & Michelini LC (1998). Chronic AT1 receptor blockade alters aortic nerve activity in hypertension. Hypertension, 31: 973-977.